|
TMEM14A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.666200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.223600E-01 |
| Normal-vs-Stage2 |
8.366400E-01 |
| Normal-vs-Stage3 |
5.124800E-01 |
| Normal-vs-Stage4 |
3.658900E-03 |
| Stage1-vs-Stage2 |
7.219200E-01 |
| Stage1-vs-Stage3 |
4.054200E-01 |
| Stage1-vs-Stage4 |
5.579100E-03 |
| Stage2-vs-Stage3 |
8.114400E-01 |
| Stage2-vs-Stage4 |
1.644810E-01 |
| Stage3-vs-Stage4 |
1.618400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.214000E-01 |
| Normal-vs-AfricanAmerican |
8.684200E-02 |
| Normal-vs-Asian |
2.239200E-01 |
| Caucasian-vs-AfricanAmerican |
2.154400E-01 |
| Caucasian-vs-Asian |
4.398000E-01 |
| AfricanAmerican-vs-Asian |
7.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.257800E-03 |
| Normal-vs-Female |
1.559940E-02 |
| Male-vs-Female |
3.32700000005293E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.064000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.936000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.904600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.052600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.247220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.077700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.612000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.954200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.231400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.064800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.557400E-03 |
| Normal-vs-Grade 2 |
5.312400E-01 |
| Normal-vs-Grade 3 |
5.552200E-01 |
| Normal-vs-Grade 4 |
1.90420000001357E-06 |
| Grade 1-vs-Grade 2 |
1.220590E-01 |
| Grade 1-vs-Grade 3 |
3.078400E-02 |
| Grade 1-vs-Grade 4 |
3.586900E-04 |
| Grade 2-vs-Grade 3 |
3.073000E-01 |
| Grade 2-vs-Grade 4 |
4.10839999998025E-06 |
| Grade 3-vs-Grade 4 |
1.950580E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.2055999999937E-05 |
| Normal-vs-ccB subtype |
3.70149999999736E-05 |
| ccA subtype-vs-ccB subtype |
4.47542003456647E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.329800E-01 |
| Normal-vs-N1 |
1.780150E-01 |
| N0-vs-N1 |
2.898600E-01 |
|
|
